---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-086130"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:15:49.786637+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# iSpecimen Q2 revenue up 76% to $2.86M; net loss narrows to $2.11M

## Summary
- Revenue $2.86M (+76% YoY); net loss $2.11M ($0.19/sh) vs $3.5M loss ($0.39/sh) in Q2 2023.
- Hired Brielan Smiechowski as SVP of Sales & Business Development.
- Next Day Quotes conversion rate 58% to purchase orders.
- Cash and securities $2.15M as of June 30, 2024, down from $5.01M at Dec 31, 2023.
- Supplier organizations reduced to 105 from 243 at year-end 2023.

## SEC filing metadata
- accession: 0001104659-24-086130
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000110465924086130/0001104659-24-086130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000110465924086130/tm2420908d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-086130
- JSON: https://secwatch.observer/filing/0001104659-24-086130.json
- Plain text: https://secwatch.observer/filing/0001104659-24-086130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.